Peptide index

Apex Peptide Index™

NAD+

Endogenous dinucleotide coenzyme, not a peptideMETABOLIC RESEARCHLEVEL 01 · Basic biology

Also referred to as: Oxidized Nicotinamide Adenine Dinucleotide

Overview

NAD+ is a naturally occurring coenzyme involved in metabolic reactions and cellular maintenance. Its relationship to aging and metabolic dysfunction has attracted research interest, but its biological importance does not establish therapeutic benefits from supplementation.

0/3 selected

Biological background

NAD+ participates in electron-transfer reactions that support cellular energy conversion, including mitochondrial metabolism. It also serves as a substrate for enzymes involved in genome maintenance and cellular stress responses. Age-associated changes in NAD+ availability are a research topic, although their extent and consequences depend on biological context.

Mechanism

Research examines NAD+ availability in relation to energy metabolism and enzyme-dependent repair processes. Sirtuins require NAD+ for their activity, providing a mechanistic link to pathways associated with stress adaptation and aging. Potential effects on oxidative damage remain distinct from demonstrated benefits in human health.

Sirtuins
  1. 01

    Molecular target

  2. 02

    Cellular signal

  3. 03

    Biological process

Research areas

Metabolic RegulationGenome MaintenanceCognitive AgingAging BiologyCellular Stress Responses

Evidence

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

What the source states

The source guide presents NAD+ as important for mitochondrial activity, genome maintenance, and age-related cellular changes. It discusses potential applications involving cognition, metabolic disorders, and lifespan-related outcomes, but the supplied material does not identify supporting studies. The guide also portrays tolerability favorably while acknowledging adverse symptoms and unresolved long-term safety.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

What remains uncertain

The extracted notes do not establish whether changing NAD+ availability produces meaningful clinical improvements or extends human lifespan. They also do not clearly distinguish evidence concerning NAD+ itself from evidence concerning related compounds or precursors.

Safety information

The guide lists skin warmth or redness, gastrointestinal symptoms, tiredness, and headaches as possible adverse effects, without evidence establishing their frequency or attribution. Safety data are limited, especially for prolonged use, and the supplied notes cannot establish a comprehensive risk profile. This information is educational and is not medical advice.

Regulatory context

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

References

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

  • NAD+ cellular repair aging
  • NAD+ supplementation clinical trials
  • Role of NAD+ in longevity and health

Editorial record

Editorial status
source reviewed
Last updated
2026-09-14
Last reviewed
2026-09-13
Language
EN

Flagged for editorial review

  • · Peptide designation is incorrect
  • · Origin section uses NAO+ rather than NAD+
  • · Longevity and therapeutic claims lack supporting references
  • · Possible conflation with NAD+ precursors
  • · Evidence rating reflects supplied support, not a systematic literature assessment

Disclaimer

APEX PHARMA 360® provides scientific and educational information for informational purposes only. The information presented on this platform is not intended to diagnose, treat, cure or prevent any disease and does not constitute medical advice, medical treatment or a recommendation to use any particular substance or compound. Scientific research and regulatory status can change over time and may differ between jurisdictions. Experimental or research-stage compounds should not be interpreted as approved medicines. Always consult an appropriately qualified healthcare professional for individual medical questions and verify applicable laws and regulatory requirements in your jurisdiction.